The FHIT gene, which spans the common fragile site FRA3B, has been shown to produce aberrant transcripts in a variety of tumor types. Homozygous deletions within the FHIT locus have been detected only in tumor-derived cell lines and LOH has been described in numerous primary tumors. Based on these ®ndings and its location on 3p, FHIT has been proposed as a tumor suppressor gene. To further study the relationship of FRA3B to the ®ndings regarding the FHIT gene and to determine the extent of FHIT mRNA alterations in early stages of tumor development, the status of the FHIT gene was evaluated in the premalignant condition of Barrett's esophagus and associated esophageal adenocarcinomas. FHIT expression was investigated by RT ± PCR in normal esophageal, Barrett's metaplasia and adenocarcinoma tissues from 15 patients. Alterations of FHIT transcripts were observed in 12/14 (86%) of Barrett's metaplasia and in 14/15 (93%) of the adenocarcinomas from the same patients. Characterization of the altered transcripts revealed FHIT mRNA lacking one or more exons, with deletion of exons 5 ± 7 being most frequent. Analysis of genomic DNA from 20 patients showed homozygous deletions involving exon 5 of FHIT in 4/20 (20%) esophageal adenocarcinomas, and 7/20 (35%) tumors demonstrated hemizygous loss. Genomic deletions also involved the BE758-6 locus, indicating that a large region is deleted. Fluorescence in situ hybridization (FISH) analysis demonstrated that this region of deletion is localized within FRA3B. Our results extend the range of tumor types in which altered FHIT transcripts have been demonstrated and show that these alterations can be seen in the premalignant stage of esophageal tumor development. These results indicate that the fragility and recombination-prone nature of FRA3B is related to tumor-speci®c chromosomal instability aecting the FHIT gene in esophageal adenocarcinoma development.
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Introduction
An unanswered question regarding genomic instability and its relationship with tumorigenesis is the extent to which chromosomal fragile sites may play a role in rearrangements and deletions seen in cancer. A possible link has been provided by the common fragile site FRA3B at 3p14.2 which lies within a region thought to harbor several tumor suppressor loci (Naylor et al., 1987; Kok et al., 1987; Zbar et al., 1987; Sato et al., 1991; Jones and Nakamura, 1992; Sanchez et al., 1994; Zeiger et al., 1994; Nawroz et al., 1994; Kastury et al., 1996) . The suggestion that a tumor suppressor gene lies directly in this region was strongly supported by the isolation of the BE758-6 probe from a Barrett's adenocarcinoma using representational dierence analysis (RDA) (Lisitsyn et al., 1995) . Recently the cloning of the FHIT (fragile histidine triad) gene, which encompasses the BE758-6 locus was reported . The FHIT gene contains 10 exons and spans a genomic region of approximately 1 Mb that includes FRA3B and the t(3;8) translocation breakpoint seen in a family with hereditary renal cell carcinoma. In contrast to its large genomic size, it encodes only a 1.1 kb transcript, the product of which is a hydrolase involved in the cleavage of diadenosine triphosphates (Barnes et al., 1996) . Interestingly, aberrant FHIT transcripts have been identi®ed in various cancers including digestive tract, lung and breast cancer Sozzi et al., 1996; Negrini et al., 1996) . The origin of the transcripts and the putative role of FHIT in carcinogenesis have been questioned since homozygous deletions for FHIT exons have only been reported in tumor-derived cell lines Negrini et al., 1996; Virgilio et al., 1996; Yanagiswa et al., 1996) . In addition, some primary tumors and cancer cell lines harbor allelic and homozygous deletions only in intronic regions which would presumably not aect FHIT function Shridar et al., 1996; Boldog et al., 1997) . Alternative hypotheses for the unusual ®ndings concerning the FHIT gene include: alternative splicing (Thiagalingam et al., 1996) , selection for another mutated gene in the region, and genomic instability at FRA3B.
We have previously mapped FRA3B to the same region of 3p14.2 and found it to extend over a large region of at least 200 kb . To study the relationship of FRA3B to the ®ndings regarding the FHIT gene and to determine the extent of FHIT mRNA alterations in early stages of tumor development, the status of the FHIT gene was evaluated in 20 patients with the premalignant condition of Barrett's esophagus and associated adenocarcinomas. Our results show that aberrant FHIT transcripts are seen in premalignant and malignant tumors of Barrett's esophagus and that genomic deletions involving FHIT exon 5 and the BE758-6 locus are also detected in these lesions. FISH analysis indicates that this region of genomic deletion coincides with the location of FRA3B, adding support for the involvement of this fragile site in the instability associated with the FHIT gene.
Results

RT ± PCR and sequence analysis on normal control tissues
In recent studies, nested RT ± PCR has been the primary approach used to determine the presence of aberrant FHIT transcripts in primary tumors and tumor cell lines (e.g. Ohta et al., 1996; Sozzi et al., 1996; Negrini et al., 1996; Virgilio et al., 1996) . It has been suggested (Thiagalingam et al., 1996) that this nested PCR strategy is susceptible to potential artifacts. To establish reproducible conditions for analysis of aberrant FHIT transcripts in esophageal tissues, a single-stage PCR ampli®cation with 30 cycles was compared to nested PCR ampli®cations using a total of 55 cycles on lymphocyte RNA from two healthy donors. Primers within exons 4 and 10 were designed because they cover the entire open reading frame of the FHIT gene. Primers similar to those used by Ohta et al. (1996) were also analysed. After a 30 cycle single-stage PCR with various primer combinations, only the expected normal-sized FHIT transcript was detected in each sample (Figure 1) .
After a second round of PCR consisting of an additional 25 cycles with various combinations of nested primers, a very strong normal-sized band and additional bands of lower molecular weight were detected (Figure 1 ). Sequence analysis showed that the 410 bp and 570 bp bands were not of FHIT origin. The 359 bp band was a FHIT transcript lacking exons 3 to 8 with a junction precisely at the splice sites of exons 2 and 9, and a 55 bp insertion at the splice sites of exons 9 and 10. The inserted sequence is not repetitive and BLAST and FASTA searches of the GenBank data base did not reveal any signi®cant homology to other sequences. In this transcript the deletion of exons and the insertion occurred precisely at the normal splice sites, suggesting that this product is not a PCR artifact. However, the fact that the aberrant FHIT transcript was detected only after 55 cycles suggests that it is present at a very low abundance. We also observed that a nested RT ± PCR approach, in contrast to a single-state PCR protocol, resulted in aberrant products that were not identical from one experiment to another. These experiments demonstrate that a single-stage RT ± PCR approach, consisting of 30 cycles, is sucient to reproducibly detect FHIT transcripts.
RT ± PCR and sequence analysis in Barrett's esophagus
The single-stage RT ± PCR protocol described above was used to analyse RNA from 15 of 20 patients (summarized in Table 1 ) and one esophageal cancer cell line. In all 15 cases, matched normal esophageal squamous mucosa was analysed and for ®ve patients normal gastric mucosa was also examined. In each of the 15 cases, a normal-sized FHIT-speci®c PCR product was detected in the normal control tissues ( Figure 2 ). In the 14 Barrett's metaplasias studied, a normal-sized band of varying intensity was observed in 10 out of 14 cases. In the other four cases, this band was barely detectable. The esophageal adenocarcinomas showed a normal-sized transcript in eight out of 15 cases. In seven cases, this transcript was nearly undetectable. The signal intensity of the normal transcript was found to generally decrease in the progression from normal esophagus to Barrett's metaplasia to adenocarcinoma, and to correlate with an increasing abundance of aberrant transcripts.
Lower molecular weight bands were detected in 12/ 14 (86%) of the Barrett's metaplasia specimens and in 14/15 (93%) esophageal adenocarcinomas ( Figure 2 ). In 5/12 of Barrett's metaplasias and in 8/14 adenocarcinomas the aberrant bands were more prominent than the normal-sized band. Due to the semiquantitative nature of PCR, this may indicate that the major form of FHIT transcripts are aberrant in the adenocarcinomas. Sequence analysis of the abnormal transcripts revealed deletions of exon 3 and 4 resulting in the junction of exon 2 ± 5, deletions of exons 4 ± 8 resulting in the junction of exon 3 ± 9, and products missing exons 5 ± 7 or 8, resulting in a junction between exon 4 to exon 8 or to exon 9. The major species of aberrant transcripts are those with deletions of exons 5 ± 7 and 5 ± 8 (Table 1) . It has been suggested that aberrant transcripts encode aberrant proteins with a dominant-negative eect . We note here that the major form of aberrant transcripts are unlikely to be translated since exon 5 contains the AUG initiator codon for synthesis of the FHIT protein. In all of the aberrant transcripts analysed by sequencing the fusion junctions coincided with normal splice sites. The normal-sized transcript present in the metaplasias and in the tumors showed the normal FHIT cDNA sequence. A previously described (Sozzi et al., 1996) 11 bp alternatively spliced region, due to the use of a cryptic acceptor splice site at the beginning of exon 10 (outside the open reading frame of the FHIT gene) was observed in the normal-sized transcript in all tissues from several patients. In some of the Barrett's metaplasias and adenocarcinomas, larger bands than the normal-sized transcript were detected. PCR-reampli®cation followed by sequencing of these bands showed that they correspond to heteroduplexes composed of smaller aberrant and normal-sized transcripts. Heteroduplex formation was also observed for a smaller-sized nondistinct band (Figure 2d , tumor lane).
In the normal control tissues from four of 15 patients, faint FHIT-speci®c altered bands were observed. These bands were, however, less intense and dierent in size from the aberrant transcripts seen in tumors. In one of these four cases aberrant transcripts of similar size and intensity to those found in tumors were detected (Figure 2c ). Sequence analysis of these bands revealed deletions of exons 5 ± 7 and 5 ± 8. In the cell line derived from an esophageal adenocarcinoma, only aberrant FHIT transcripts were detected with deletions of exons 5 ± 7, 5 ± 8 and 3 ± 7. Two cases with esophageal squamous cell carcinoma were also analysed. In both cases only a normal-sized transcript was detected.
In a limited number of cases, two rounds of PCR ampli®cation were performed. This resulted in an overrepresentation of the aberrant transcripts described above, as well as additional bands that were not of FHIT origin in normal control tissues, Barrett's metaplasias and esophageal adenocarcinomas.
Analysis of genomic deletions
To determine if the RT-results corresponded to the presence of genomic deletions in the FHIT gene, DNA from 20 patients with Barrett's metaplasia and esophageal adenocarcinoma were analysed by Southern blot analysis. Analysis focused on the region involving exon 5 and the BE758-6 locus (Lisitsyn et al., 1995) , which maps to FHIT intron 5 and is approximately 40 kb downstream from exon 5. It was shown previously that both probes map within the region of homozygous deletion in tumor-derived cell lines and are in the FRA3B region (see below). Exon 5 contains the AUG initiator codon, therefore deletions should abolish synthesis of the FHIT protein.
A probe for exon 3, which maps proximal to the t(3;8) translocation breakpoint and to the FRA3B region was also used. Southern blots were reprobed with a control probe for a single copy gene CMKLR1 (Gantz et al., 1996) . Southern blot results are summarized in Table 2 and examples are shown in Figure 3 . Four out of 20 adenocarcinomas (20%) showed virtually complete loss of exon 5, providing evidence for homozygous deletion of exon 5. RT ± PCR results of these tumors had shown a nearly undetectable normal-sized band and aberrant FHIT transcripts (Table 1 ). In three of these adenocarcinomas (15%), homozygous deletions were also observed using BE758-6 probe. No homozygous deletions were detected in the Barrett's metaplasia, or in the corresponding normal tissues, with either probe (Table 1) .
Results were interpreted as representing hemizygous deletions when the intensity of the hybridization signal was reduced by more than 50% of the signal present in the normal esophageal control tissue. Adenocarcinomas from six out of 20 patients (30%) showed hemizygous loss with the BE758-6 and the exon 5 probes. Hemizygous loss was also seen at both loci in the Barrett's metaplasia from four of these six patients. In the remaining two cases, one had loss only at the BE758-6 locus and the other had no loss using either probe.
The results show that hemizygous and homozygous deletions of FHIT exon 5 occur in esophageal adenocarcinomas and usually include the BE758-6 locus, indicating that the deletions involve a large genomic region. No deletions were detected in the Barrett's metaplasias or associated adenocarcinomas with the exon 3 probe (Table 1) .
In the esophageal adenocarcinoma cell line that expressed only aberrant FHIT transcripts, homozygous deletions were detected with both the exon 5 and the BE758-6 probes.
Localization of FHIT exon 5 and BE758-6 within FRA3B
To localize FHIT exon 5 and the BE758-6 locus in relation to the FRA3B region, speci®c lambda phage clones were used as FISH probes on metaphase spreads derived from normal lymphocytes treated with aphidicolin for fragile site expression. The¯uorescent signals of the exon 5 and the BE758-6 probes relative to FRA3B breakage were found to localize either proximal, distal or span the FRA3B region. Results of the FISH analyses are summarized in Table 3 and an example of an exon 5 lambda phage clone showing variable hybridization with respect to FRA3B is shown in Figure 4 . The dierent hybridization signals obtained for a single clone indicate that FRA3B contains several breaks which vary in size. Taken together with our previous data Paradee et al., 1996) , these results indicate that the position of fragile site breakage within the FHIT gene is variable and de®nes a region of frequent breakage associated with FRA3B of over 300 kb. Exon 5 of the FHIT gene and the BE758-6 locus map within this region of aphidicolin-induced gaps and breaks. Thus FRA3B extends at least from exon 4 to within intron 5 of the FHIT gene.
Discussion
The initial report of mutations in the FHIT gene included the ®nding of homozygous deletions in tumor Table 2 Deletions at FHIT exon 5 and the BE758-6 locus in Barrett's metaplasia and adenocarcinoma
Barrett's metaplasia Adenocarcinoma
Exon 5 (Table 1) : 13, 10, 7, 12. Probes speci®c for exon 5 (upper panels a ± d), BE758-6 (middle panels a ± d) and an control probe (lower panel) were used. For cases (a) and (b) homozygous deletion involving exon 5 and the BE758-6 locus were observed in the adenocarcinomas (T). In case (c) a hemizygous loss of exon 5 and the BE758-6 locus in Barrett's metaplasia (B) and adenocarcinoma (T) is shown. For case (d) no genomic deletions were detected N=The number of metaphase spreads scored. The % Prox, % Dist and % Crossing refer to the percentage of total signals detected either proximal, distal or crossing the aphidicolin-induced breakage, respectively derived cell lines . Homozygous deletions have not been previously reported in primary tumors. Our results show that homozygous deletions involving exon 5 of the FHIT gene are frequently seen in esophageal adenocarcinoma. Additional hemizygous deletions are seen in both Barrett's metaplasia and adenocarcinomas. The fact that deletions are seen in the premalignant stage demonstrates that this is an early event. The deletions usually involve the BE758-6 locus, indicating that a large genomic region is deleted. We demonstrated that this large region of loss coincides with the location of FRA3B. No deletions were detected at the FHIT exon 3 locus, which maps outside of the FRA3B region. This indicates that the instability and recombinogenic nature of FRA3B is related to the genomic deletions of the FHIT gene in Barrett's esophagus.
Comparison of the RT ± PCR results with the genomic deletion data shows that homozygous deletions of exon 5 are consistent with absence or nearly undetectable levels of the normal-sized FHIT transcript. However, it does not explain why those tumors demonstrating no detectable genomic deletions of exon 5 exhibit the same abundance and type of aberrant transcripts, lacking exons 5 ± 7 and 5 ± 8, as those tumors with loss of exon 5 (e.g. case 20 in Table  3 ; Figure 2d ). In case 14 (Table 1) only an aberrant transcript lacking exons 3 and 4 was detected; however there was no evidence for a genomic deletion in exon 3. It had been reported that some tumor-derived cell lines retain all FHIT exons yet express only aberrant transcripts lacking multiple exons . There was no reported evidence in these cell lines for splice site mutations that could cause the skipping of multiple exons (Druck et al., 1997) . These observations suggest that some aberrant transcripts are generated by a post-transcriptional mechanism such as abnormal or alternative splicing. While alternative splicing of the FHIT gene may occur, we found no evidence for alternative splicing in our control tissues. Low abundance aberrant transcripts lacking exons 5 ± 7 or 5 ± 8 were detected in only one of the 15 control tissues. It has been suggested that removal of exon 8 is due to alternative splicing (Boldog et al., 1997) . In our analysis, a FHIT transcript lacking exon 8 was detected in only one of 15 adenocarcinomas. Removal of multiple exons due to alternative splicing is a rare event and usually occurs in genes with a large number of exons (Streuli and Saito, 1989) , and alternative splicing that removed nearly the entire open reading frame would be highly unusual. Alternatively, aberrant transcripts could be generated by abnormal splicing. Genomic rearrangements in the large intronic regions, perhaps related to FRA3B, could lead to abnormal splicing. This is supported by the fact that some aberrant transcripts harbor insertions exactly at splice sites, suggestive of a genomic rearrangement that generates new splice sites, aecting mainly introns 4, 7 and 8 Sozzi et al., 1996; Virgilio et al., 1996; Yanagiswa et al., 1996) . Unusual splicing events have recently been shown to occur in the b catenin gene in melanoma cell lines (Rubinfeld et al., 1997) and in the DCC gene in both normal and neoplasic tissues (Nigro et al., 1991) .
FHIT is the ®rst gene found to span a common fragile site, FRA3B. FRA3B is the most sensitive site on normal human chromosomes for the formation of gaps or breaks when DNA replication is perturbed by aphidicolin or folate stress (Glover et al., 1984) . It displays in vitro a number of characteristics associated with highly unstable and recombinogenic DNA including increased sister chromatid exchange (Glover and Stein, 1987) , production of translocations and deletions (Glover and Stein, 1988; Wang et al., 1993) and acting as a preferred site of recombination with transfected pSVneo-plasmid DNA (Rassool et al., 1991) and perhaps viral DNA . It has been suggested that fragile sites may play a mechanistic role in chromosome breakage and rearrangements in cancer (Le Beau and Rowley, 1984; Yunis and Soreng, 1984) . The instability of the FHIT gene in tumors supports this hypothesis, at least for FRA3B. Genomic instability is a frequent characteristic of tumor cells, and common fragile sites and associated genes may be highly susceptible targets for such instability.
In Barrett's esophagus the progression from the premalignant to the malignant stage is associated with increased genomic instability due to p53 mutations (Neshat et al., 1994) . In contrast to colon cancer, p53 alterations appear to be an early event in Barrett's metaplasia, preceding the appearance of adenocarcinoma. A model has been proposed in which p53 loss leads to large-scale karyotypic instability that is displayed by aneuploidy, ampli®cations and deletions (Donehower et al., 1995) . Therefore, the deletions in the FHIT gene described in this study could be a consequence of p53-mediated large scale karyotypic instability to which fragile sites are especially sensitive. The chronic in¯ammation process seen in Barrett's Figure 4 Localization of FHIT exon 5 in FRA3B by FISH. Partial metaphase spreads from a single experiment in which the fragile site was induced in normal lymphocytes with aphidicolin. A lambda clone containing FHIT exon 5 was used as a FISH probe. From left to right the hybridization signal indicated by the arrows can be seen to occur proximal to, distal to, and on both sides of the fragile site, respectively esophagus could contribute as well. Several studies have shown that chronic in¯ammation induces direct DNA damage and is associated with carcinogenesis (Birnboim, 1982; Weitberg et al., 1983; Weitzman et al., 1985) . Interestingly, the in¯ammation-induced DNA damage displays many of the same features, such as sister chromatid exchange and DNA breaks, that have been described for fragile sites.
FHIT has been proposed to be a frequently deleted tumor suppressor gene, and it is clear that functional studies are necessary to determine its proposed role in carcinogenesis. It has recently been noted that tumorderived cell lines with homozygous deletions have a decreased level or absence of FHIT protein expression (Druck et al., 1997) . However, it is currently unknown if loss of FHIT protein expression functionally contributes to the tumor phenotype. Our data and that of others suggests that instability at FRA3B is directly associated with deletions and genomic rearrangements in the FHIT gene. While this does not exclude the tumor suppressor gene hypothesis it may in part explain the mechanism behind the frequent alterations found in the FHIT gene.
The ®nding that FRA3B is associated with the FHIT gene which appears to be highly unstable in cancer, points the way to other genes associated with fragile sites and instability in cancer.
Materials and methods
Tissue specimens
Tissues were obtained from patients undergoing surgical resection for esophageal cancer. Tumor and normal tissue specimens were frozen in liquid nitrogen and stored at 7708C. The normal esophagus, Barrett's metaplasia, and adenocarcinoma from 20 patients were evaluated. Normal gastric mucosa from ®ve of these patients was also examined. Normal and tumor tissue from two cases of esophageal squamous cell carcinoma, and an esophageal Barrett's adenocarcinoma cell line were also analysed. Histological grade and tumor stage were evaluated. The percentage of tumor tissue was determined for each sample using hematoxylin-stained cryostat sections of the tumors. Only those samples containing greater than 70% tumor cells were utilized for analysis.
RNA and DNA isolation
Total RNA was extracted from frozen tumors and normal tissues as described (Chomzynski and Sacchi, 1987) . Genomic DNA was extracted using standard methods (Sambrook et al., 1989) .
RT ± PCR analysis
5 mg of total RNA was reverse transcripted in a ®nal volume of 20 ml, using oligo-(dT) primer and AMLV-RT (Promega) according to the manufacturer's speci®cations. 4 ml of the RT reaction was used for one round of PCR ampli®cation consisting of 30 cycles at 958C for 1 min, 568C for 1 min and 728C for 1 min. For ampli®cation of FHIT transcripts the following PCR oligonucleotide primers were used: exon 1-speci®c primer 5U2 , exon 4-speci®c primer (5'-GGAATACCTG-CCTGCTTAGA-3' nucleotides), exon 10-speci®c primer (5'-GCAGCAGAGAAGGAAGTTTA-3'). For veri®cation of RNA integrity, control RT ± PCR ampli®cations using primers speci®c for the ATP7A gene were performed (Dierick et al., 1995) .
PCR-products were analysed on 2% agarose gels, transferred to nylon membranes and hybridized either with a FHIT speci®c 32 P-labeled cDNA or a FHIT-speci®c 32 Plabeled oligonucleotide. In a few cases no sequences were obtained, requiring reprobing of Southern blots with an internal oligonucleotide to con®rm that aberrant bands were of FHIT origin.
Sequencing
Single bands were cut from gels and puri®ed directly using Qiaex II Gel Extraction Kit (Qiagen). Fifty to 100 ng DNA was subjected to automated¯uorescence sequence analysis using primers for either exons 1, 4 or 10.
Southern analysis
DNA was digested with EcoRI, fractionated by electrophoresis in 0.9% agarose gels and transferred to nylon membranes. Southern blots were sequentially hybridized with several probes: PCR-products speci®c for exon 3 and 5 , BE758-6 (Lisitsyn et al., 1995) and CMKLR1 (Gantz et al., 1996) , which was used as a control for equal loading. Speci®city of PCR products was con®rmed by sequencing. Following each hybridization, blots were stripped of probe as recommended by the manufacturer. Quanti®cation of DNA band intensities was performed with a scanning laser densitometer (Molecular Dynamics) using the Image-Quant program. Hemizygous loss was determined when the relative ratios between band intensities changed more than 50% after equalization with the ratios for the normal control probe.
FISH analysis
PHA-stimulated whole-blood lymphocyte cultures were grown in RPMI 1640 medium (Irvine Scienti®c) containing 10% fetal calf serum, 4 mM L-glutamine, and penicillin/ streptomycin (200 units/ml, 200 mg/ml). Fragile sites were induced with 0.3 ± 0.4 mM aphidicolin (Sigma) for 26 h prior to harvesting (Glover et al., 1984) . Harvesting and chromosome preparation were carried out using conventional techniques (Barch, 1991) . Fluorescence in situ hybridization (FISH) was performed as previously described . Images were captured using a cooled CCD camera (Photometrics) coupled to a Zeiss epi¯uorescence microscope equipped with a Zeiss ®lter set allowing simultaneous visualization of FITC and DAPI. Grayscale images were pseudocolored using the software Gene Join (Yale University).
